Detalhe da pesquisa
1.
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Lab Invest
; 104(4): 100321, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154497
2.
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676430
3.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
N Engl J Med
; 385(23): 2123-2131, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874631
4.
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay Performance.
Mod Pathol
; 37(4): 100445, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341130
5.
Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627034
6.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
7.
Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study.
Gynecol Oncol
; 178: 96-101, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839314
8.
Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.
J Surg Oncol
; 128(1): 111-118, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975108
9.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897700
10.
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients.
Int J Gynecol Cancer
; 33(2): 257-262, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581488
11.
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Int J Gynecol Cancer
; 33(7): 1083-1089, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001891
12.
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
Int J Gynecol Cancer
; 33(5): 734-740, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759002
13.
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
Int J Gynecol Cancer
; 33(1): 42-49, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104079
14.
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial.
Int J Gynecol Cancer
; 33(12): 1966-1969, 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935524
15.
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.
Int J Gynecol Cancer
; 33(8): 1304-1309, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208019
16.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Int J Gynecol Cancer
; 33(2): 223-230, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631151
17.
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 59(3): 248-252, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273034
18.
Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC).
Br J Cancer
; 126(7): 1047-1054, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923575
19.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851799
20.
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
N Engl J Med
; 380(9): 822-832, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811909